News
The US Food and Drug Administration is starting to publish letters the agency sent to pharmaceutical companies when their ...
6h
NewsNation on MSNFDA Commissioner: ‘We want to focus on food’FDA Commissioner told NewsNation the agency is focused on fighting childhood obesity and diabetes. Dr. Marty Makary discussed ...
On this week's episode of "The Readout LOUD": a closer look at the NIH’s grant-cutting legal playbook, FDA transparency ...
The U.S. Food and Drug Administration released more than 200 of its so-called complete response letters from its archive on ...
Joe Lonsdale, co-founder of the large government contractor Palantir, wants to embed a team of 15 to 20 “elite engineers” ...
The U.S. Food and Drug Administration (FDA) on Thursday published more than 200 complete response letters ((CRLs)), through ...
The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial ...
The trove of more than 200 letters is part of a pledge of transparency from the agency, with the intention to increase public ...
Investors have long asked the FDA to share its reasons for rejecting drugs, arguing that companies can use the agency’s silence on the matter to mislead the market.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results